Published in Eur J Pediatr on February 15, 2016
Effects of Prophylactic Indomethacin on Vasopressor-Dependent Hypotension in Extremely Preterm Infants. J Pediatr (2016) 0.77
Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes. J Pediatr (2017) 0.76
Effect of prophylactic indomethacin administration and early feeding on spontaneous intestinal perforation in extremely low-birth-weight infants. J Perinatol (2016) 0.75
Risk of nonsteroidal anti-inflammatory drug-associated renal dysfunction among neonates diagnosed with patent ductus arteriosus and treated with gentamicin. J Perinatol (2017) 0.75
Prophylactic Indomethacin Revisited. J Pediatr (2017) 0.75
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform (2008) 71.12
Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med (2001) 3.77
Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics (1994) 3.74
Patent ductus arteriosus: evidence for and against treatment. J Pediatr (2007) 2.10
Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr (2007) 2.07
Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res (2000) 1.94
The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr (2009) 1.82
Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias. J Pediatr (2012) 1.61
Long-term morbidities associated with vocal cord paralysis after surgical closure of a patent ductus arteriosus in extremely low birth weight infants. J Perinatol (2009) 1.60
Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol (2010) 1.50
Lasting effects of preterm birth and neonatal brain hemorrhage at 12 years of age. Pediatrics (2009) 1.49
Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr (1999) 1.31
Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics (2000) 1.30
Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev (2010) 1.29
Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics (2009) 1.26
Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics (2009) 1.25
Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants. Arch Dis Child Fetal Neonatal Ed (2010) 1.24
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (2003) 1.13
Indomethacin prophylaxis for preterm infants: the impact of 2 multicentered randomized controlled trials on clinical practice. J Pediatr (2007) 1.05
Ibuprofen lysine (NeoProfen) for the treatment of patent ductus arteriosus. Proc (Bayl Univ Med Cent) (2007) 0.98
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev (2015) 0.94
Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. Cochrane Database Syst Rev (2008) 0.92
Scoliosis in patients with aortic coarctation and patent ductus arteriosus: does standard posterolateral thoracotomy play a role in the development of the lateral curve of the spine? Pediatr Cardiol (2009) 0.92
Current evidence on the safety profile of NSAIDs for the treatment of PDA. J Matern Fetal Neonatal Med (2011) 0.91
Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child Fetal Neonatal Ed (2008) 0.91
Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (2013) 0.89
Treatment to prevent patency of the ductus arteriosus: beneficial or harmful? J Pediatr (2006) 0.89
Hemodynamically significant PDA: an echocardiographic and clinical assessment of incidence, natural history, and outcome in very low birth weight infants maintained in negative fluid balance. Pediatr Cardiol (1985) 0.88
Hypotension following patent ductus arteriosus ligation: the role of adrenal hormones. J Pediatr (2014) 0.87
Drug pricing in pediatrics: the egregious example of indomethacin. Pediatrics (2007) 0.83
Effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus in preterm infants. Am J Perinatol (2013) 0.81